title: Rate-limiting step: can different effects of antihypertensives on central blood pressure be translated into outcomes?
authors.forename: Laurie A
authors.initials: LA
authors.lastname: Tomlinson
authors.forename: Viknesh
authors.initials: V
authors.lastname: Selvarajah
authors.forename: Ian B
authors.initials: IB
authors.lastname: Wilkinson
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use; D001011:Aorta / Q000503:physiopathology; D001578:Benzopyrans / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects*; D002339:Carotid Arteries / Q000187:drug effects / Q000503:physiopathology; D004983:Ethanolamines / Q000627:therapeutic use*; D005263:Femoral Artery / Q000187:drug effects / Q000503:physiopathology; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D008790:Metoprolol / Q000627:therapeutic use*; D000068577:Nebivolol; D011674:Pulse; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome
chemical_list: D000959:Antihypertensive Agents; D001578:Benzopyrans; D004983:Ethanolamines; D000068577:Nebivolol; D008790:Metoprolol